Oritavancin (LY-333328)
Oritavancin is an FDA-approved semisynthetic glycopeptide antibiotic for skin infections. It exhibits rapid bactericidal activity in vitro against a wide range of Gram-positive bacteria, including resistant strains like MRSA. Its research applications extend to in vivo models of bacterial infection and studies on novel antimicrobial mechanisms.
Product Specifications
CAS Number
171099-57-3
Field of Research
Infectious Disease & Virology, Pharmacology & Drug Discovery
Smiles
[H][C@]12NC (=O) [C@] ([H]) (NC (=O) [C@]3 ([H]) NC (=O) [C@H] (CC (N) =O) NC (=O) [C@H] (NC (=O) [C@@H] (CC (C) C) NC) [C@H] (O) c4ccc (Oc5cc3cc (Oc3ccc (cc3Cl) [C@H]1O[C@H]1C[C@] (C) (N) [C@@H] (O) [C@H] (C) O1) c5O[C@@H]1O[C@H] (CO) [C@@H] (O) [C@H] (O) [C@H]1O[C@H]1C[C@] (C) (NCc3ccc (cc3) -c3ccc (Cl) cc3) [C@@H] (O) [C@H] (C) O1) c (Cl) c4) c1ccc (O) c (c1) -c1c (O) cc (O) cc1[C@H] (NC2=O) C (O) =O
Molecular Formula
C86H97Cl3N10O26
Molecular Weight
1793.12
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
GTR15401161 1 Vial
Lentiviral human SOX30 sgRNA gene knockout kit - Lentiviral human SOX30 sgRNA gene knockout kit (100)
Sign In for Pricing
View Details